ZENAS BIOPHARMA, INC. — Cash Flow Charts
10 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-94.0% -$18M
$-37M
Free Cash Flow↑+100.0% +$74K
$0
Investing Cash Flow
$40M
Financing Cash Flow↑+7500.8% +$139M
$141M
Capex↓-100.0% -$74K
$0
Stock-Based Comp↑+37.9% +$2M
$8M
Debt Issued
$0
D&A↓-69.7% -$23K
$10K
SBC Allocated Expense↑+37.9% +$2M
$8M